Heron Therapeutics, Inc.
HRTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000818033
No open-market purchases or sales by Heron Therapeutics, Inc. insiders were filed in the last 90 days; 163 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Heron Therapeutics, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 167 | 4 | 163 | 0 |
| Shares | 156.9M | 74.9K | 133.5M | −23.3M (−14.8%) |
| Value | $125.6M | $59.9K | $57.1M | −$68.5M (−54.5%) |
4 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (22)
Institutions that held Heron Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marshall Wace, LLP | 2,354,193 | $1.01M | 0.00% |
| Diadema Partners LP | 458,723 | $195.8K | 0.07% |
| Virtu Financial LLC | 283,239 | $121.0K | 0.00% |
| Persistent Asset Partners Ltd | 117,090 | $50.0K | 0.02% |
| Centiva Capital, LP | 45,507 | $19.4K | 0.00% |
| Neuberger Berman Group LLC | 38,987 | $16.6K | 0.00% |
| Creative Planning | 35,862 | $15.3K | 0.00% |
| DDFG, Inc | 32,903 | $14.0K | 0.00% |
| HRT Financial LP | 27,024 | $11.0K | 0.00% |
| Pallas Capital Advisors LLC | 25,699 | $11.0K | 0.00% |
| Jane Street Group, LLC | 25,672 | $11.0K | 0.00% |
| Two Sigma Securities, LLC | 20,754 | $8.86K | 0.00% |
| J.W. Cole Advisors, Inc. | 15,000 | $6.40K | 0.00% |
| Principal Financial Group Inc | 12,074 | $5.15K | 0.00% |
| Spectrum Investment Advisors, Inc. | 11,731 | $5.01K | 0.00% |
| JMN Financial LLC | 11,269 | $4.81K | 0.00% |
| Brighton Jones LLC | 11,133 | $4.75K | 0.00% |
| Global Retirement Partners, LLC | 4,018 | $1.72K | 0.00% |
| Fortitude Family Office, LLC | 888 | $379 | 0.00% |
| Parkside Financial Bank & Trust | 560 | $240 | 0.00% |
| Nisa Investment Advisors, LLC | 331 | $141 | 0.00% |
| Wealth Enhancement Trust Services, Inc. | 320 | $137 | 0.00% |
Sold out (22)
Institutions that held Heron Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| OrbiMed Advisors LLC | 9,816,940 | $7.85M |
| Palisade Capital Management LLC | 6,140,639 | $4.91M |
| Monaco Asset Management SAM | 858,122 | $686.6K |
| Citadel Advisors LLC | 759,269 | $607.5K |
| Orchard Capital Managment, LLC | 680,432 | $544.4K |
| Universal- Beteiligungs- und Servicegesellschaft mbH | 458,766 | $367.1K |
| Palumbo Wealth Management LLC | 412,496 | $330.0K |
| XTX Topco Ltd | 209,481 | $167.6K |
| Glenmede Trust Co NA | 82,050 | $65.6K |
| Nine Masts Capital Ltd | 53,399 | $42.7K |
| State of Wyoming | 50,618 | $40.5K |
| Manufacturers Life Insurance Company, The | 45,988 | $36.8K |
| ACT Advisors, LLC. | 28,443 | $22.8K |
| Voya Investment Management LLC | 25,601 | $20.5K |
| Red Door Wealth Management, LLC | 18,900 | $15.1K |
| Anchyra Partners LLC | 18,043 | $14.4K |
| Colony Group, LLC | 17,514 | $14.0K |
| Nicolet Bankshares Inc | 16,000 | $12.9K |
| Envestnet Asset Management Inc | 13,591 | $10.9K |
| MAI Capital Management | 695 | $557 |
| True Wealth Design, LLC | 271 | $217 |
| Root Financial Partners, LLC | 263 | $210 |
Not filed for Q2 2026 yet (4)
Institutions that held Heron Therapeutics, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Anfield Capital Management, LLC | 30,000 | $24.0K |
| CWM, LLC | 28,890 | $23.1K |
| Skopos Labs, Inc. | 15,927 | $12.7K |
| Sunbelt Securities, Inc. | 37 | $30 |